ZIM
IRMD icon

Zacks Investment Management’s iRadimed IRMD Stock Holding History

Zacks Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,500
Closed -$236K – 736
2025
Q1 		$236K Hold
4,500
– – ﹤0.01% 586
2024
Q4 		$248K Buy
+4,500
New +$237K ﹤0.01% 594

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Zacks Investment Management's IRMD Position: Q2 2025 in Review

Zacks Investment Management sold out of iRadimed (IRMD) in Q2 2025, closing a stake of 4,500 shares — an estimated $236K sold.

Zacks Investment Management first reported a position in IRMD in Q4 2024 and held it in 2 quarters. The position peaked at $248K in Q4 2024. 162 funds tracked by Wall St. Rank hold IRMD as of Q2 2025.

  • Zacks Investment Management reported no remaining iRadimed position as of Q2 2025 after selling out during the quarter.
  • Zacks Investment Management sold 4,500 iRadimed shares in Q2 2025, an estimated $236K.
  • Zacks Investment Management first reported a position in iRadimed in Q4 2024 and held it in 2 quarters.
  • Zacks Investment Management's iRadimed position peaked at $248K in Q4 2024.
  • 162 funds tracked by Wall St. Rank held iRadimed as of Q2 2025.

Based on Zacks Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.